Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 235142, 6 pages
http://dx.doi.org/10.1155/2011/235142
Review Article

Adaptive Immune Responses in Primary Cutaneous Sarcoidosis

1Unit of Dermatology, University of Padua, Via Cesare Battisti 206, 35128 Padua, Italy
2Respiratory Diseases Section, Department of Clinical Medicine and Immunological Sciences, Siena University, 53100 Siena, Italy
3Department of Clinical and Experimental Medicine, University of Padua, Via Cesare Battisti 206, 35128 Padua, Italy

Received 31 July 2010; Accepted 27 January 2011

Academic Editor: E. Shevach

Copyright © 2011 Matteo Bordignon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Giuffrida and F. A. Kerdel, “Sarcoidosis,” Dermatologic Clinics, vol. 20, no. 3, pp. 435–447, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Iannuzzi, B. A. Rybicki, and A. S. Teirstein, “Sarcoidosis,” New England Journal of Medicine, vol. 357, no. 21, pp. 2153–2108, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Miyara, Z. Amoura, C. Parizot et al., “The immune paradox of sarcoidosis and regulatory T cells,” Journal of Experimental Medicine, vol. 203, no. 2, pp. 359–370, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. R. P. Baughman, E. E. Lower, and R. M. Du Bois, “Sarcoidosis,” Lancet, vol. 361, no. 9363, pp. 1111–1118, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. G. Zissel, A. Prasse, and J. Müller-Quernheim, “Immunologic response of sarcoidosis,” Seminars in Respiratory and Critical Care Medicine, vol. 31, no. 4, pp. 390–403, 2010. View at Publisher · View at Google Scholar · View at PubMed
  6. M. Ota, R. Amakawa, K. Uehira et al., “Involvement of dendritic cells in sarcoidosis,” Thorax, vol. 59, no. 5, pp. 408–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L. C. Zaba, G. P. Smith, M. Sanchez, and S. D. Prystowsky, “Dendritic cells in the pathogenesis of sarcoidosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 1, pp. 32–39, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. G. Tchernev, “Cutaneous sarcoidosis: the “great imitator”: etiopathogenesis, morphology, differential diagnosis, and clinical management,” American Journal of Clinical Dermatology, vol. 7, no. 6, pp. 375–382, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Lodha, M. Sanchez, and S. Prystowsky, “Sarcoidosis of the skin: a review for the pulmonologist,” Chest, vol. 136, no. 2, pp. 583–596, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. J. C. English, P. J. Patel, and K. E. Greer, “Sarcoidosis,” Journal of the American Academy of Dermatology, vol. 44, no. 5, pp. 725–743, 2001. View at Publisher · View at Google Scholar · View at PubMed
  11. N. J. Ball, G. T. Kho, and M. Martinka, “The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases,” Journal of Cutaneous Pathology, vol. 31, no. 2, pp. 160–168, 2004. View at Publisher · View at Google Scholar
  12. R. Katta, “Cutaneous sarcoidosis: a dermatologic masquerader,” American Family Physician, vol. 65, no. 8, pp. 1581–1584, 2002. View at Google Scholar
  13. I. Ahmed and S. R. Harshad, “Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?” Journal of the American Academy of Dermatology, vol. 54, no. 1, pp. 55–60, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. A. Selim, E. Ehrsam, M. B. Atassi, and A. Khachemoune, “Scar sarcoidosis: a case report and brief review,” Cutis, vol. 78, no. 6, pp. 418–422, 2006. View at Google Scholar
  15. O. P. Sharma and I. C. Papanikolaou, “Lupus pernio: a tale of four characters in search of a malady,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 26, no. 2, pp. 167–171, 2009. View at Google Scholar
  16. D. G. James and W. J. Williams, “Kveim-Siltzbach test revisited,” Sarcoidosis, vol. 8, no. 1, pp. 6–9, 1991. View at Google Scholar
  17. E. Richter, Y. P. Kataria, G. Zissel, J. Homolka, M. Schlaak, and J. Müller-Quernheim, “Analysis of the Kveim-Siltzbach test reagent for bacterial DNA,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 6, pp. 1981–1984, 1999. View at Google Scholar
  18. Y. P. Kataria and H. K. Park, “Dynamics and mechanism of the sarcoidal granuloma: detecting T cell subsets, non-T cells, and immunoglobulins in biopsies at varying intervals of Kveim-Siltzbach test sites,” Annals of the New York Academy of Sciences, vol. 465, pp. 221–232, 1986. View at Google Scholar
  19. Y. P. Kataria and J. F. Holter, “Immunology of sarcoidosis,” Clinics in Chest Medicine, vol. 18, no. 4, pp. 719–739, 1997. View at Google Scholar
  20. M. De Jager, W. Blokx, A. Warris et al., “Immunohistochemical features of cutaneous granulomas in primary immunodeficiency disorders: a comparison with cutaneous sarcoidosis,” Journal of Cutaneous Pathology, vol. 35, no. 5, pp. 467–472, 2008. View at Publisher · View at Google Scholar · View at PubMed
  21. A. Noor and K. S. Knox, “Immunopathogenesis of sarcoidosis,” Clinics in Dermatology, vol. 25, no. 3, pp. 250–258, 2007. View at Publisher · View at Google Scholar · View at PubMed
  22. A. Belkhou, R. Younsi, I. El Bouchti, and S. El Hassani, “Rituximab as a treatment alternative in sarcoidosis,” Joint Bone Spine, vol. 75, no. 4, pp. 511–512, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. W. R. Heath and F. R. Carbone, “Dendritic cell subsets in primary and secondary T cell responses at body surfaces,” Nature Immunology, vol. 10, no. 12, pp. 1237–1244, 2009. View at Publisher · View at Google Scholar · View at PubMed
  24. F. O. Nestle, P. Di Meglio, J. Z. Qin, and B. J. Nickoloff, “Skin immune sentinels in health and disease,” Nature Reviews Immunology, vol. 9, no. 10, pp. 679–691, 2009. View at Publisher · View at Google Scholar · View at PubMed
  25. A. G. Martin, M. E. Kleinhenz, and C. A. Elmets, “Immunohistologic identification of antigen-presenting cells in cutaneous sarcoidosis,” Journal of Investigative Dermatology, vol. 86, no. 6, pp. 625–629, 1986. View at Google Scholar
  26. A. Kurata, Y. Terado, M. Izumi, Y. Fujioka, and F. E. Franke, “Where does the antigen of cutaneous sarcoidosis come from?” Journal of Cutaneous Pathology, vol. 37, no. 2, pp. 211–221, 2010. View at Publisher · View at Google Scholar · View at PubMed
  27. F. A. Bonilla and H. C. Oettgen, “Adaptive immunity,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, pp. S33–S40, 2010. View at Publisher · View at Google Scholar · View at PubMed
  28. A. K. Gerke and G. Hunninghake, “The immunology of sarcoidosis,” Clinics in Chest Medicine, vol. 29, no. 3, pp. 379–390, 2008. View at Publisher · View at Google Scholar · View at PubMed
  29. J. T. Klein, T. D. Horn, J. D. Forman, R. F. Silver, A. S. Teirstein, and D. R. Moller, “Selection of oligoclonal Vβ-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis,” Journal of Immunology, vol. 154, no. 3, pp. 1450–1460, 1995. View at Google Scholar
  30. M. Mempel, B. Flageul, F. Suarez et al., “Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas: presence of Vα24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Vα repertoire,” American Journal of Pathology, vol. 157, no. 2, pp. 509–523, 2000. View at Google Scholar
  31. V. K. Singh, S. Mehrotra, and S. S. Agarwal, “The paradigm of Th1 and Th2 cytokines: its relevance to aotoimmunity and allergy,” Immunologic Research, vol. 20, no. 2, pp. 147–161, 1999. View at Google Scholar
  32. C. Agostini, A. Meneghin, and G. Semenzato, “T-lymphocytes and cytokines in sarcoidosis,” Current Opinion in Pulmonary Medicine, vol. 8, no. 5, pp. 435–440, 2002. View at Google Scholar
  33. C. Gurrieri, M. Bortoli, E. Brunetta, F. Piazza, and C. Agostini, “Cytokines, chemokines and other biomolecular markers in sarcoidosis,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 22, no. 1, pp. S9–S14, 2005. View at Google Scholar
  34. S. Pestka, “The interferons: 50 years after their discovery, there is much more to learn,” Journal of Biological Chemistry, vol. 282, no. 28, pp. 20047–20051, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. S. Pestka, C. D. Krause, and M. R. Walter, “Interferons, interferon-like cytokines, and their receptors,” Immunological Reviews, vol. 202, pp. 8–32, 2004. View at Publisher · View at Google Scholar · View at PubMed
  36. A. Aronsohn and N. Reau, “Long-term outcomes after treatment with interferon and ribavirin in HCV patients,” Journal of Clinical Gastroenterology, vol. 43, no. 7, pp. 661–671, 2009. View at Publisher · View at Google Scholar · View at PubMed
  37. C. Tortorella, N. Napoli, E. Panella, A. Antonaci, A. Gentile, and S. Antonaci, “Asymptomatic systemic sarcoidosis arising 5 years after IFN-α treatment for chronic hepatitis C: a new challenge for clinicians,” Journal of Interferon and Cytokine Research, vol. 24, no. 11, pp. 655–658, 2004. View at Publisher · View at Google Scholar
  38. C. I. Daïen, A. Monnier, P. Claudepierre et al., “Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases,” Rheumatology, vol. 48, no. 8, pp. 883–886, 2009. View at Publisher · View at Google Scholar · View at PubMed
  39. V. Neglia, S. Sookoian, M. Herrera et al., “Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b,” Journal of Cutaneous Medicine and Surgery, vol. 5, no. 5, pp. 406–408, 2001. View at Google Scholar
  40. C. J. Rogers, R. Romagosa, and V. Vincek, “Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C,” Journal of the American Academy of Dermatology, vol. 50, no. 4, pp. 649–650, 2004. View at Publisher · View at Google Scholar · View at PubMed
  41. F. Fantini, C. Padalino, G. Gualdi, P. Monari, and A. Giannetti, “Cutaneous lesions as initial signs of interferon α-induced sarcoidosis: report of three new cases and review of the literature,” Dermatologic Therapy, vol. 22, no. 1, pp. S1–S7, 2009. View at Publisher · View at Google Scholar · View at PubMed
  42. A. Alonso-Pérez, M. Ballestero-Díez, J. Fraga, A. García-Díez, and J. Fernández-Herrera, “Cutaneous sarcoidosis by interferon therapy in a patient with melanoma,” Journal of the European Academy of Dermatology and Venereology, vol. 20, no. 10, pp. 1328–1329, 2006. View at Publisher · View at Google Scholar · View at PubMed
  43. F. Pelletier, P. Manzoni, P. Jacoulet, P. Humbert, and F. Aubin, “Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma,” Cutis, vol. 80, no. 5, pp. 441–445, 2007. View at Google Scholar
  44. C. Suárez-García, A. Pérez-Gil, S. Pereira-Gallardo et al., “Interferon-induced cutaneous sarcoidosis in melanoma,” Melanoma Research, vol. 19, no. 6, pp. 391–394, 2009. View at Publisher · View at Google Scholar · View at PubMed
  45. H. Chen, L. W. Wang, Y. Q. Huang, and Z. J. Gong, “Interferon-alpha induces high expression of APOBEC3G and STAT-1 in Vitro and in Vivo,” International Journal of Molecular Sciences, vol. 20, no. 11, pp. 3501–3512, 2010. View at Google Scholar
  46. J. T. Rosenbaum, S. Pasadhika, E. D. Crouser et al., “Hypothesis: sarcoidosis is a STAT1-mediated disease,” Clinical Immunology, vol. 132, no. 2, pp. 174–183, 2009. View at Publisher · View at Google Scholar · View at PubMed
  47. F. Bazzoni and B. Beutler, “The tumor necrosis factor ligand and receptor families,” New England Journal of Medicine, vol. 334, no. 26, pp. 1717–1725, 1996. View at Publisher · View at Google Scholar
  48. R. P. Baughman and M. Iannuzzi, “Tumour necrosis factor in sarcoidosis and its potential for targeted therapy,” BioDrugs, vol. 17, no. 6, pp. 425–431, 2003. View at Publisher · View at Google Scholar
  49. R. P. Baughman, E. E. Lower, and M. Drent, “Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 25, no. 2, pp. 76–89, 2008. View at Google Scholar
  50. L. Mallbris, A. Ljungberg, M. A. Hedblad, P. Larsson, and M. Ståhle-Bäckdahl, “Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-α therapy,” Journal of the American Academy of Dermatology, vol. 48, no. 2, pp. 290–293, 2003. View at Publisher · View at Google Scholar · View at PubMed
  51. M. P. Heffernan and M. J. Anadkat, “Recalcitrant cutaneous sarcoidosis responding to infliximab,” Archives of Dermatology, vol. 141, no. 7, pp. 910–911, 2005. View at Publisher · View at Google Scholar · View at PubMed
  52. M. P. Heffernan and D. I. Smith, “Adalimumab for treatment of cutaneous sarcoidosis,” Archives of Dermatology, vol. 142, no. 1, pp. 17–19, 2006. View at Publisher · View at Google Scholar · View at PubMed
  53. A. M. Thielen, C. Barde, J. H. Saurat, and E. Laffitte, “Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists,” Dermatology, vol. 219, no. 1, pp. 59–62, 2009. View at Publisher · View at Google Scholar · View at PubMed
  54. C. Bachmeyer, L. Blum, B. Petitjean, F. Kemiche, and E. Pertuiset, “Granulomatous tattoo reaction in a patient treated with etanercept,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 4, pp. 550–552, 2007. View at Publisher · View at Google Scholar · View at PubMed
  55. F. Dhaille, V. Viseux, A. Caudron et al., “Cutaneous sarcoidosis occurring during anti-TNF-Alpha treatment: report of two cases,” Dermatology, vol. 220, no. 3, pp. 234–237, 2010. View at Publisher · View at Google Scholar · View at PubMed
  56. A. K. Palucka, J. P. Blanck, L. Bennett, V. Pascual, and J. Banchereau, “Cross-regulation of TNF and IFN-α in autoimmune diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 9, pp. 3372–3377, 2005. View at Publisher · View at Google Scholar · View at PubMed
  57. T. Cantaert, D. Baeten, P. P. Tak, and L. G. van Baarsen, “Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance,” Arthritis Research and Therapy, vol. 12, p. 219, 2010. View at Google Scholar
  58. Y. Eishi, M. Suga, I. Ishige et al., “Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis,” Journal of Clinical Microbiology, vol. 40, no. 1, pp. 198–204, 2002. View at Publisher · View at Google Scholar
  59. E. Bassi, F. Poli, A. Charachon, P. Claudepierre, and J. Revuz, “Infliximab-induced acne: report of two cases,” British Journal of Dermatology, vol. 156, no. 2, pp. 402–403, 2007. View at Publisher · View at Google Scholar · View at PubMed
  60. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at PubMed
  61. M. Facco, A. Cabrelle, A. Teramo et al., “Sarcoidosis is a Th1/Th17 multisystem disorder,” Thorax, vol. 66, no. 2, pp. 144–150, 2011. View at Publisher · View at Google Scholar · View at PubMed